Systematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes

[1]  A. Bacolla,et al.  DHX9 helicase is involved in preventing genomic instability induced by alternatively structured DNA in human cells , 2013, Nucleic acids research.

[2]  K. Knudsen,et al.  Transcriptional Roles of PARP1 in Cancer , 2014, Molecular Cancer Research.

[3]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[4]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[5]  D. Hong,et al.  Systematic investigation of cancer-associated somatic point mutations in SNP databases , 2013, Nature Biotechnology.

[6]  Linghua Wang,et al.  From human genome to cancer genome: The first decade , 2013, Genome research.

[7]  L. Tamagnone.  Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. , 2012, Cancer cell.

[8]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[9]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[10]  W. Foulkes,et al.  DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.

[11]  S. Fröhling,et al.  Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines , 2015, Scientific Reports.

[12]  Donna D. Zhang,et al.  The emerging role of the Nrf2–Keap1 signaling pathway in cancer , 2013, Genes & development.

[13]  Kei-Hoi Cheung,et al.  A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations , 2013, BMC Bioinformatics.

[14]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[15]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[16]  Liwei Wang,et al.  The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutations , 2010, Nature Structural &Molecular Biology.

[17]  R. Bernards.  Unlikely suspects identified in neuroblastoma conspiracy. , 2014, Cancer discovery.

[18]  The Cancer Genome Atlas Research Network,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[19]  K. Katoh,et al.  MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. , 2002, Nucleic acids research.

[20]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[21]  Lawrence A. Donehower,et al.  The somatic genomic landscape of chromophobe renal cell carcinoma. , 2014, Cancer cell.

[22]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[23]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[24]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[25]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[26]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[27]  M. Pagano,et al.  Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer , 2008, Nature Reviews Cancer.

[28]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[29]  Keith A. Boroevich,et al.  Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity , 2015, Nature Communications.

[30]  David Tamborero,et al.  OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..

[31]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[32]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[33]  J. Uhm.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .

[34]  A. Dingwall,et al.  The cancer COMPASS: navigating the functions of MLL complexes in cancer. , 2015, Cancer genetics.

[35]  Matthew J. Davis,et al.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.

[36]  Gary D Bader,et al.  Comprehensive identification of mutational cancer driver genes across 12 tumor types , 2013, Scientific Reports.

[37]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[38]  P. Chiao,et al.  ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer , 2015, Cell Research.

[39]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[40]  The Cancer Genome Atlas Research Network.  COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[41]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[42]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[43]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .